BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 16835384)

  • 1. Gene transfer of cytidine deaminase protects myelopoiesis from cytidine analogs in an in vivo murine transplant model.
    Rattmann I; Kleff V; Sorg UR; Bardenheuer W; Brueckner A; Hilger RA; Opalka B; Seeber S; Flasshove M; Moritz T
    Blood; 2006 Nov; 108(9):2965-71. PubMed ID: 16835384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resistance to cytarabine and gemcitabine and in vitro selection of transduced cells after retroviral expression of cytidine deaminase in human hematopoietic progenitor cells.
    Bardenheuer W; Lehmberg K; Rattmann I; Brueckner A; Schneider A; Sorg UR; Seeber S; Moritz T; Flasshove M
    Leukemia; 2005 Dec; 19(12):2281-8. PubMed ID: 16304576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug resistance to 5-aza-2'-deoxycytidine, 2',2'-difluorodeoxycytidine, and cytosine arabinoside conferred by retroviral-mediated transfer of human cytidine deaminase cDNA into murine cells.
    Eliopoulos N; Cournoyer D; Momparler RL
    Cancer Chemother Pharmacol; 1998; 42(5):373-8. PubMed ID: 9771951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemoprotection of murine hematopoietic cells by combined gene transfer of cytidine deaminase (CDD) and multidrug resistance 1 gene (MDR1).
    Brennig S; Lachmann N; Buchegger T; Hetzel M; Schambach A; Moritz T
    J Exp Clin Cancer Res; 2015 Dec; 34():148. PubMed ID: 26651614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myeloprotection by cytidine deaminase gene transfer in antileukemic therapy.
    Lachmann N; Brennig S; Phaltane R; Flasshove M; Dilloo D; Moritz T
    Neoplasia; 2013 Mar; 15(3):239-48. PubMed ID: 23479503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Forced expression of cytidine deaminase confers resistance to cytosine arabinoside and gemcitabine.
    Neff T; Blau CA
    Exp Hematol; 1996 Sep; 24(11):1340-6. PubMed ID: 8862446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of drug-resistant transduced cells with cytosine nucleoside analogs using the human cytidine deaminase gene.
    Beauséjour CM; Eliopoulos N; Momparler L; Le NL; Momparler RL
    Cancer Gene Ther; 2001 Sep; 8(9):669-76. PubMed ID: 11593336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo enrichment of cytidine deaminase gene-modified hematopoietic cells by prolonged cytosine-arabinoside application.
    Brennig S; Rattmann I; Lachmann N; Schambach A; Williams DA; Moritz T
    Cytotherapy; 2012 Apr; 14(4):451-60. PubMed ID: 22242831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to cytosine arabinoside by retrovirally mediated gene transfer of human cytidine deaminase into murine fibroblast and hematopoietic cells.
    Momparler RL; Eliopoulos N; Bovenzi V; Létourneau S; Greenbaum M; Cournoyer D
    Cancer Gene Ther; 1996; 3(5):331-8. PubMed ID: 8894252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of cytidine deaminase as inhibitor of granulocyte-macrophage colony formation.
    Bøyum A; Løvhaug D; Seeberg E; Nordlie EM
    Exp Hematol; 1994 Feb; 22(2):208-14. PubMed ID: 7507861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of the best blood compartment to measure cytidine deaminase activity to stratify for optimal gemcitabine or cytarabine treatment.
    Peters GJ; Honeywell RJ; Maulandi M; Giovannetti E; Losekoot N; Etienne-Grimaldi MC; Milano G; Serdjebi C; Ciccolini J;
    Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):403-12. PubMed ID: 24940698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient in vivo regulation of cytidine deaminase expression in the haematopoietic system using a doxycycline-inducible lentiviral vector system.
    Lachmann N; Brennig S; Pfaff N; Schermeier H; Dahlmann J; Phaltane R; Gruh I; Modlich U; Schambach A; Baum C; Moritz T
    Gene Ther; 2013 Mar; 20(3):298-307. PubMed ID: 22592598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic activity of 2',2'-difluorodeoxycytidine, 5-aza-2'-deoxycytidine and cytosine arabinoside in cells transduced with deoxycytidine kinase gene.
    Beauséjour CM; Gagnon J; Primeau M; Momparler RL
    Biochem Biophys Res Commun; 2002 May; 293(5):1478-84. PubMed ID: 12054682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfer of the cytidine deaminase cDNA into hematopoietic cells.
    Flasshove M; Frings W; Schröder JK; Moritz T; Schütte J; Seeber S
    Leuk Res; 1999 Nov; 23(11):1047-53. PubMed ID: 10576510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant gene products of two natural variants of the human cytidine deaminase gene confer different deamination rates of cytarabine in vitro.
    Kirch HC; Schröder J; Hoppe H; Esche H; Seeber S; Schütte J
    Exp Hematol; 1998 May; 26(5):421-5. PubMed ID: 9590659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth inhibition of granulocyte-macrophage colony-forming cells by human cytidine deaminase requires the catalytic function of the protein.
    Gran C; Bøyum A; Johansen RF; Løvhaug D; Seeberg EC
    Blood; 1998 Jun; 91(11):4127-35. PubMed ID: 9596658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Forced expression of cytidine deaminase confers sensitivity to capecitabine.
    Morita T; Matsuzaki A; Kurokawa S; Tokue A
    Oncology; 2003; 65(3):267-74. PubMed ID: 14657601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfection of murine fibroblast cells with human cytidine deaminase cDNA confers resistance to cytosine arabinoside.
    Momparler RL; Laliberté J; Eliopoulos N; Beauséjour C; Cournoyer D
    Anticancer Drugs; 1996 May; 7(3):266-74. PubMed ID: 8791999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexpression of rat glutathione S-transferase A3 and human cytidine deaminase by a bicistronic retroviral vector confers in vitro resistance to nitrogen mustards and cytosine arabinoside in murine fibroblasts.
    Létourneau S; Palerme JS; Delisle JS; Beauséjour CM; Momparler RL; Cournoyer D
    Cancer Gene Ther; 2000 May; 7(5):757-65. PubMed ID: 10830723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct reversal of DNA damage by mutant methyltransferase protein protects mice against dose-intensified chemotherapy and leads to in vivo selection of hematopoietic stem cells.
    Ragg S; Xu-Welliver M; Bailey J; D'Souza M; Cooper R; Chandra S; Seshadri R; Pegg AE; Williams DA
    Cancer Res; 2000 Sep; 60(18):5187-95. PubMed ID: 11016647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.